Portfolio Growth TSCP is a middle-market PE firm with a track record of acquiring and scaling companies across Life Sciences & Healthcare, Software & Technology, and Business & Consumer Services. Potential sales opportunity: approach TSCP with high-growth target companies in strategic sectors aligned to their platforms, emphasizing scalable business models and potential add-on acquisitions.

Platform Expansion Recent activity includes launches and acquisitions across services and tech-enabled sectors, such as Complex Claims Recovery and BuildClinical, plus pest control and fast-casual investments. Potential sales opportunity: present integrated solutions or digital enablement, including analytics, CRM, or marketing tech that can support portfolio add-ons and cross-sell across TSCP-backed platforms.

Global Reach TSCP invests globally from St. Louis, targeting multiple industries and leveraging international opportunities. Potential sales opportunity: propose scalable international market entry services, cross-border expansion tools, and region-specific compliance solutions to support portfolio companies globalizing operations.

Financial Scale Reported revenue range of 100M to 250M places TSCP as a substantial mid-market investor seeking value creation through growth and acquisitions. Potential sales opportunity: tailor enterprise-grade solutions that drive growth metrics, such as revenue management, optimization, and integration platforms designed for PE-backed businesses.

Strategic Value Portfolio focus on accelerating growth organically and via acquisitions suggests emphasis on operational improvements and deal-ready value creation. Potential sales opportunity: provide due diligence readiness tools, integration playbooks, and post-close optimization services to accelerate time-to-value for new platform acquisitions.